Rankings
Publications
Sources
Publishers
Scholars
Organizations
About
Login
Register
Home
Publications
Supplementary Methods from IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer
Home
Publications
Supplementary Methods from IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer
Supplementary Methods from IGF2 Autocrine-Mediated IGF1R Activation Is a Clinically Relevant Mechanism of Osimertinib Resistance in Lung Cancer
TM
Tadashi Manabe
Tadashi Manabe
HY
Hiroyuki Yasuda
Hiroyuki Yasuda
HT
Hideki Terai
Hideki Terai
HK
Harumi Kagiwada
Harumi Kagiwada
JH
Junko Hamamoto
Junko Hamamoto
TE
Toshiki Ebisudani
Toshiki Ebisudani
KK
Keigo Kobayashi
Keigo Kobayashi
KM
Keita Masuzawa
Keita Masuzawa
SI
Shinnosuke Ikemura
Shinnosuke Ikemura
IK
Ichiro Kawada
Ichiro Kawada
YH
Yuichiro Hayashi
Yuichiro Hayashi
Kazuhiko Fukui
Kazuhiko Fukui
See more
Open Access
Publisher Website
Google Scholar
Cite
Download
Share
Download
3 April 2023
other
Published by
American Association for Cancer Research (AACR)
https://doi.org/10.1158/1541-7786.22516806.v1
Abstract
Supplementary Methods includes 4 methods: "Preparation of cell lysates for protein array", "Phosphorylation activity measurement on the array", "Estimation of active pathway by protein array" and "Software".
Keywords
PROTEIN
PHOSPHORYLATION
SUPPLEMENTARY
IGF2
IGF1R
LUNG
AUTOCRINE
SOFTWARE
OSIMERTINIB
LYSATES
All Articles
Open Access